Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Liver Neoplasm Malignant Primary in Switzerland
Total 0 results
Nothing found
Sponsors and Collaborators
National Institute of Health and Medical Research 1061, Montpellier
Richard M. Fairbanks School of Public Health AT IUPUI
Radiomedix, Inc.
Refocus Group, Inc.
Aryn Knight
APT Foundation, Inc.
LuEsther T. Mertz Retinal Research Center
Third Affiliated Hospital of Third Military Medical University
Francine Behar-Cohen
Accunea Ltd.
Association for the Blind and Visually Impaired
Congressionally Directed Medical Research Programs
Private Ortopedia Hospital, Seyhan Adana
Zhiwu Huang, Ph.D.
Erol Aktunc
Cure Cancer Worldwide Corporation
Central Institute of Psychiatry, Ranchi, India
Key Tech
Mitaka USA, Inc.
Lishui Hospital of TCM
View Full List
Medical Conditions
Root Abscess
Neuroectodermal Tumor
Granulomatous Disease, Chronic
Poor Medication Adherence
Memory Disorders
Control Nausea and Vomiting
Urinary Bladder Neurogenic Dysfunction
Bladder Recurrence
Inoperable Stage III Non-small Cell Lung Cancer
Endoscopic Surveillance
0.5-14 Year Old Children With Nephroblastoma
Small Intestine Cancer
Malignant Tumor of Urinary System (Disorder)
Pharmacokinetics of Ipragliflozin
Humerus Fracture Displaced Proximal
Anticoagulant Prophylaxis/Therapy
Parental
Macrocephaly Autism Syndrome
Atherosclerosis Coronary Artery With Angina Pectoris
Bladder Cancer Recurrent
View Full List
Drug Interventions
APG2575 800 mg
Vehicle
Biphasic insulin aspart 30
Clozapine 100 mg
The drug "Rutan 0.1".
SAR408701 (Tusamitamab ravtansine)
Varenicline Controlled Release 1.2 mg
Sparsentan
Salvinorin A
FTD regimen
Fibrin Sealant
Letrozole
Cyclosporine A
Everolimus
Bupropion Extended Release Oral Tablet
Idelalisib
Campath 1H
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Elafibranor 80mg
Ceralasertib
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Algeria
Contract Research Organizations in Cambodia
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Estonia
Contract Research Organizations in Finland
Contract Research Organizations in Ireland
Contract Research Organizations in Madagascar
Contract Research Organizations in Mauritania
Contract Research Organizations in Montenegro
Contract Research Organizations in Netherlands
Contract Research Organizations in Zambia
CRO list by country
CROs in Jordan
Arab Pharmaceutical Industry Consulting Co
MCT
SGS
Mesned CRO
All CROs in Jordan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe